Elizabeth Thompson, MD, discusses pediatric cancer, proton therapy, and her work as a peer reviewer for CURiE.
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Grants Approval to Lirafugratinib for Advanced Cholangiocarcinoma with FGFR2 Alteration
2
Emerging Endocrine Doublets and Serial ESR1 Testing in HR+/HER2− mBC
3
Subcutaneous Pembrolizumab Approved in Japan for All Tumor Indications
4
Isatuximab Combo Increases MRD Negativity in MRD-Positive Multiple Myeloma
5